Literature DB >> 21914794

ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner.

Hiroyuki Takatsu1, Keiko Baba, Takahiro Shima, Hiroyuki Umino, Utako Kato, Masato Umeda, Kazuhisa Nakayama, Hye-Won Shin.   

Abstract

Type IV P-type ATPases (P4-ATPases) are putative phospholipid flippases that translocate phospholipids from the exoplasmic (lumenal) to the cytoplasmic leaflet of lipid bilayers and are believed to function in complex with CDC50 proteins. In Saccharomyces cerevisiae, five P4-ATPases are localized to specific cellular compartments and are required for vesicle-mediated protein transport from these compartments, suggesting a role for phospholipid translocation in vesicular transport. The human genome encodes 14 P4-ATPases and three CDC50 proteins. However, the subcellular localization of human P4-ATPases and their interactions with CDC50 proteins are poorly understood. Here, we show that class 5 (ATP10A, ATP10B, and ATP10D) and class 6 (ATP11A, ATP11B, and ATP11C) P4-ATPases require CDC50 proteins, primarily CDC50A, for their exit from the endoplasmic reticulum (ER) and final subcellular localization. In contrast, class 2 P4-ATPases (ATP9A and ATP9B) are able to exit the ER in the absence of exogenous CDC50 expression: ATP9B, but not ATP11B, was able to exit the ER despite depletion of CDC50 proteins by RNAi. Although ATP9A and ATP9B show a high overall sequence similarity, ATP9A localizes to endosomes and the trans-Golgi network (TGN), whereas ATP9B localizes exclusively to the TGN. A chimeric ATP9 protein in which the N-terminal cytoplasmic region of ATP9A was replaced with the corresponding region of ATP9B was localized exclusively to the Golgi. These results indicate that ATP9B is able to exit the ER and localize to the TGN independently of CDC50 proteins and that this protein contains a Golgi localization signal in its N-terminal cytoplasmic region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914794      PMCID: PMC3207472          DOI: 10.1074/jbc.M111.281006

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.

Authors:  Coen C Paulusma; Annemiek Groen; Cindy Kunne; Kam S Ho-Mok; Astrid L Spijkerboer; D Rudi de Waart; Frans J Hoek; Heleen Vreeling; Kees A Hoeben; Jan van Marle; Ludmila Pawlikowska; Laura N Bull; Alan F Hofmann; A S Knisely; Ronald P J Oude Elferink
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

Review 3.  Lipid asymmetry in membranes.

Authors:  J A Op den Kamp
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

Review 4.  Transbilayer phospholipid movement and the clearance of apoptotic cells.

Authors:  Patrick Williamson; Robert A Schlegel
Journal:  Biochim Biophys Acta       Date:  2002-12-30

Review 5.  Regulation of transbilayer plasma membrane phospholipid asymmetry.

Authors:  David L Daleke
Journal:  J Lipid Res       Date:  2002-12-16       Impact factor: 5.922

6.  A novel membrane protein, Ros3p, is required for phospholipid translocation across the plasma membrane in Saccharomyces cerevisiae.

Authors:  Utako Kato; Kazuo Emoto; Charlotta Fredriksson; Hidemitsu Nakamura; Akinori Ohta; Toshihide Kobayashi; Kimiko Murakami-Murofushi; Tetsuyuki Kobayashi; Masato Umeda
Journal:  J Biol Chem       Date:  2002-07-19       Impact factor: 5.157

7.  Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.

Authors:  Yuriko Katoh; Masaru Katoh
Journal:  Oncol Rep       Date:  2004-10       Impact factor: 3.906

8.  Cdc50p, a protein required for polarized growth, associates with the Drs2p P-type ATPase implicated in phospholipid translocation in Saccharomyces cerevisiae.

Authors:  Koji Saito; Konomi Fujimura-Kamada; Nobumichi Furuta; Utako Kato; Masato Umeda; Kazuma Tanaka
Journal:  Mol Biol Cell       Date:  2004-04-16       Impact factor: 4.138

9.  Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis.

Authors:  Thomas Pomorski; Ruben Lombardi; Howard Riezman; Philippe F Devaux; Gerrit van Meer; Joost C M Holthuis
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

10.  Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation.

Authors:  S M van den Eijnde; M J van den Hoff; C P Reutelingsperger; W L van Heerde; M E Henfling; C Vermeij-Keers; B Schutte; M Borgers; F C Ramaekers
Journal:  J Cell Sci       Date:  2001-10       Impact factor: 5.285

View more
  53 in total

1.  Outside of the box: recent news about phospholipid translocation by P4 ATPases.

Authors:  Alex Stone; Patrick Williamson
Journal:  J Chem Biol       Date:  2012-07-15

2.  Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs.

Authors:  Bartholomew P Roland; Tomoki Naito; Jordan T Best; Cayetana Arnaiz-Yépez; Hiroyuki Takatsu; Roger J Yu; Hye-Won Shin; Todd R Graham
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

3.  Phospholipid Flippase ATP10A Translocates Phosphatidylcholine and Is Involved in Plasma Membrane Dynamics.

Authors:  Tomoki Naito; Hiroyuki Takatsu; Rie Miyano; Naoto Takada; Kazuhisa Nakayama; Hye-Won Shin
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

4.  The CDC50A extracellular domain is required for forming a functional complex with and chaperoning phospholipid flippases to the plasma membrane.

Authors:  Katsumori Segawa; Sachiko Kurata; Shigekazu Nagata
Journal:  J Biol Chem       Date:  2017-12-24       Impact factor: 5.157

5.  ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.

Authors:  Dirk R de Waart; Jyoti Naik; Karina S Utsunomiya; Suzanne Duijst; Kam Ho-Mok; A Ruth Bolier; Johan Hiralall; Laura N Bull; Piter J Bosma; Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Hepatology       Date:  2016-04-06       Impact factor: 17.425

6.  Phospholipid-flipping activity of P4-ATPase drives membrane curvature.

Authors:  Naoto Takada; Tomoki Naito; Takanari Inoue; Kazuhisa Nakayama; Hiroyuki Takatsu; Hye-Won Shin
Journal:  EMBO J       Date:  2018-03-29       Impact factor: 11.598

7.  Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells.

Authors:  Angela Y Liou; Laurie L Molday; Jiao Wang; Jens Peter Andersen; Robert S Molday
Journal:  J Biol Chem       Date:  2019-03-08       Impact factor: 5.157

8.  ATP11C mutation is responsible for the defect in phosphatidylserine uptake in UPS-1 cells.

Authors:  Naoto Takada; Hiroyuki Takatsu; Rie Miyano; Kazuhisa Nakayama; Hye-Won Shin
Journal:  J Lipid Res       Date:  2015-09-29       Impact factor: 5.922

9.  ATP11B mediates platinum resistance in ovarian cancer.

Authors:  Myrthala Moreno-Smith; J B Halder; Paul S Meltzer; Tamas A Gonda; Lingegowda S Mangala; Rajesha Rupaimoole; Chunhua Lu; Archana S Nagaraja; Kshipra M Gharpure; Yu Kang; Cristian Rodriguez-Aguayo; Pablo E Vivas-Mejia; Behrouz Zand; Rosemarie Schmandt; Hua Wang; Robert R Langley; Nicholas B Jennings; Cristina Ivan; Jeremy E Coffin; Guillermo N Armaiz; Justin Bottsford-Miller; Sang Bae Kim; Margaret S Halleck; Mary J C Hendrix; William Bornman; Menashe Bar-Eli; Ju-Seog Lee; Zahid H Siddik; Gabriel Lopez-Berestein; Anil K Sood
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

10.  Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.

Authors:  Hiroyuki Takatsu; Gaku Tanaka; Katsumori Segawa; Jun Suzuki; Shigekazu Nagata; Kazuhisa Nakayama; Hye-Won Shin
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.